Drug recall · February 14, 2024
Lansoprazole Delayed-Release Capsules USP recall
Why: CGMP Deviations: Inadequate induction sealing on bottles, capsules were observed with bubbles on band seal, capsules with holes and spheres sticking to capsules. Also coding details were missing on one bottle.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lansoprazole Delayed-Release Capsules USP, 15 mg, 14-count bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228, India, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ. 08816. NDC 16571-742-41
- Lots / codes
Lot # 411987 Exp: 05/2025
- Quantity
- 4260 bottles
- Company
- NATCO Pharma Limited, Rangareddy
- Distribution
- Nationwide in the USA
- Initiated
- February 1, 2024 · Voluntary: Firm initiated
- Classified
- February 8, 2024
- Reported
- February 14, 2024
- Ended
- February 6, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lansoprazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.